Perspective Therapeutics, Inc. (CATX)
NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 02:01PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.03B |
| Enterprise Value | 1.03B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 13.74 |
| Enterprise Value/Revenue | 68.73 |
| Enterprise Value/EBITDA | -26.26 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.43 |
| 52-Week Change 3 | 170.77% |
| S&P500 52-Week Change 3 | 25.59% |
| 52 Week High 3 | 1.9000 |
| 52 Week Low 3 | 0.2100 |
| 50-Day Moving Average 3 | 1.3690 |
| 200-Day Moving Average 3 | 0.6684 |
Share Statistics
| Avg Vol (3 month) 3 | 4.39M |
| Avg Vol (10 day) 3 | 4.59M |
| Shares Outstanding 5 | 586.92M |
| Implied Shares Outstanding 6 | 586.92M |
| Float 8 | 354.17M |
| % Held by Insiders 1 | 23.42% |
| % Held by Institutions 1 | 15.04% |
| Shares Short (Apr 15, 2024) 4 | 10.43M |
| Short Ratio (Apr 15, 2024) 4 | 1.62 |
| Short % of Float (Apr 15, 2024) 4 | 2.24% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.78% |
| Shares Short (prior month Mar 15, 2024) 4 | 1.88M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -2,855.02% |
Management Effectiveness
| Return on Assets (ttm) | -32.81% |
| Return on Equity (ttm) | -57.70% |
Income Statement
| Revenue (ttm) | 1.43M |
| Revenue Per Share (ttm) | 0.00 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -39.96M |
| Net Income Avi to Common (ttm) | -37.45M |
| Diluted EPS (ttm) | -0.1400 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.24M |
| Total Cash Per Share (mrq) | 0.02 |
| Total Debt (mrq) | 2.55M |
| Total Debt/Equity (mrq) | 3.39% |
| Current Ratio (mrq) | 1.08 |
| Book Value Per Share (mrq) | 0.27 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -36.91M |
| Levered Free Cash Flow (ttm) | -8.27M |
© 2024 Yahoo. All rights reserved.